USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Revenue (Most Recent Fiscal Year) | $854.50M |
Net Income (Most Recent Fiscal Year) | $42.03M |
PE Ratio (Current Year Earnings Estimate) | 11.56 |
PE Ratio (Trailing 12 Months) | 12.22 |
PEG Ratio (Long Term Growth Estimate) | 0.96 |
Price to Sales Ratio (Trailing 12 Months) | 0.64 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.07 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 7.99 |
Pre-Tax Margin (Trailing 12 Months) | 7.53% |
Net Margin (Trailing 12 Months) | 3.98% |
Return on Equity (Trailing 12 Months) | 8.94% |
Return on Assets (Trailing 12 Months) | 6.74% |
Current Ratio (Most Recent Fiscal Quarter) | 2.05 |
Quick Ratio (Most Recent Fiscal Quarter) | 1.51 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
Inventory Turnover (Trailing 12 Months) | 2.54 |
Book Value per Share (Most Recent Fiscal Quarter) | $28.45 |
Earnings per Share (Most Recent Fiscal Quarter) | $0.73 |
Earnings per Share (Most Recent Fiscal Year) | $2.59 |
Diluted Earnings per Share (Trailing 12 Months) | $1.82 |
Exchange | NYSE |
Sector | Consumer Defensive |
Industry | Packaged Foods |
Common Shares Outstanding | 18.62M |
Free Float | 18.51M |
Market Capitalization | $561.86M |
Average Volume (Last 20 Days) | 0.18M |
Beta (Past 60 Months) | 0.60 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 0.63% |
Percentage Held By Institutions (Latest 13F Reports) | 54.25% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |